It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2017.
2017 | Aurangabad, Maharashtra, India | ActiveByennet Pharmaceutical Private Limited, a active private limited company, was established on 05 April 2017 in Aurangabad, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2017PTC293416. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.92 M.
It upholds a compliant status. Its leadership includes Balaji Tukaram Sangle (Additional Director), Manjushri Sangle (Director). Past directors included Asmita Aghav Amar, Ashwini Jaybhaye Janu. It holds ₹1.50 M open charges and ₹1.92 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. B-11, Yashwant Sankul-B, Gajanan Maharaj Mandir Road,, Aurangabad, Maharashtra, 431005.
U51909MH2017PTC293416
293416
05 April 2017
₹1.00 Cr
₹5.92 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Byennet Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balaji Tukaram Sangle | Additional Director | 15 May 2017 | Current |
| Manjushri Sangle | Director | 05 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2019 | Past |
| Pramod Abcsdd | Director | 17 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Byennet Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.42% increase. The company also saw a substantial improvement in profitability, with a 51.18% increase in profit. The company's net worth moved up by a moderate rise of 1.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Byennet Pharmaceutical had a promoter holding of 57.43% and a public holding of 42.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹1,923,900.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2023 | Others | ₹1.50 M | Open |
| 26 Aug 2019 | State Bank Of India | ₹1.92 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Byennet Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Byennet Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Byennet Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Byennet Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Byennet Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100793365 was registered on 05 Sep 2023. was recorded as a recent event.
Progress on A charge registered on 26 Aug 2019 via Charge ID 100293074 with State Bank Of India was fully satisfied on 15 Mar 2023. was documented.
Progress on A charge with State Bank Of India of Rs. 0.19 Cr registered on 26 Aug 2019 with Charge ID 100293074 was modified on 27 Jul 2020. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 0.19 Cr with Charge ID 100293074 was registered on 26 Aug 2019. was documented.
The CIN of Byennet Pharmaceutical Private Limited is U51909MH2017PTC293416.
Byennet Pharmaceutical Private Limited is headquartered at Flat No. B-11, Yashwant Sankul-B, Gajanan Maharaj Mandir Road,, Aurangabad, Maharashtra, 431005.
Byennet Pharmaceutical Private Limited was incorporated on 05 April 2017.
The current directors of Byennet Pharmaceutical Private Limited are
The primary industry of Byennet Pharmaceutical Private Limited is Trade.
Byennet Pharmaceutical Private Limited is unlisted.
The authorized capital of Byennet Pharmaceutical Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.92 M.
The compliance status of Byennet Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX